These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 31908888)

  • 1. The challenge of drug resistance in pancreatic ductal adenocarcinoma: a current overview.
    Quiñonero F; Mesas C; Doello K; Cabeza L; Perazzoli G; Jimenez-Luna C; Rama AR; Melguizo C; Prados J
    Cancer Biol Med; 2019 Nov; 16(4):688-699. PubMed ID: 31908888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacotherapeutic strategies for treating pancreatic cancer: advances and challenges.
    Diab M; Azmi A; Mohammad R; Philip PA
    Expert Opin Pharmacother; 2019 Apr; 20(5):535-546. PubMed ID: 30592647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential Role of Exosomes in the Chemoresistance to Gemcitabine and Nab-Paclitaxel in Pancreatic Cancer.
    Comandatore A; Immordino B; Balsano R; Capula M; Garajovà I; Ciccolini J; Giovannetti E; Morelli L
    Diagnostics (Basel); 2022 Jan; 12(2):. PubMed ID: 35204377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The therapeutic targeting of the FGFR1/Src/NF-κB signaling axis inhibits pancreatic ductal adenocarcinoma stemness and oncogenicity.
    Lai SW; Bamodu OA; Tsai WC; Chang YM; Lee WH; Yeh CT; Chao TY
    Clin Exp Metastasis; 2018 Oct; 35(7):663-677. PubMed ID: 29987671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-410-3p attenuates gemcitabine resistance in pancreatic ductal adenocarcinoma by inhibiting HMGB1-mediated autophagy.
    Xiong J; Wang D; Wei A; Ke N; Wang Y; Tang J; He S; Hu W; Liu X
    Oncotarget; 2017 Dec; 8(64):107500-107512. PubMed ID: 29296182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of microRNA-based therapy for pancreatic cancer.
    Fesler A; Ju J
    J Pancreatol; 2019 Dec; 2(4):147-151. PubMed ID: 32133215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Galeterone and its analogs inhibit Mnk-eIF4E axis, synergize with gemcitabine, impede pancreatic cancer cell migration, invasion and proliferation and inhibit tumor growth in mice.
    Kwegyir-Afful AK; Murigi FN; Purushottamachar P; Ramamurthy VP; Martin MS; Njar VCO
    Oncotarget; 2017 Aug; 8(32):52381-52402. PubMed ID: 28881737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gemcitabine enhances OSI-027 cytotoxicity by upregulation of miR-663a in pancreatic ductal adenocarcinoma cells.
    Huang B; Wang J; Chen Q; Qu C; Zhang J; Chen E; Zhang Y; Wang Y; Ni L; Liang T
    Am J Transl Res; 2019; 11(1):473-485. PubMed ID: 30788003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysbindin promotes pancreatic ductal adenocarcinoma metastasis by activating NF-κB/MDM2 via miR-342-3p.
    Zhu D; Zheng S; Fang C; Guo X; Han D; Tang M; Fu H; Jiang M; Xie N; Nie Y; Yao X; Chen Y
    Cancer Lett; 2020 May; 477():107-121. PubMed ID: 32120026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic trends in pancreatic ductal adenocarcinoma (PDAC).
    Chandana S; Babiker HM; Mahadevan D
    Expert Opin Investig Drugs; 2019 Feb; 28(2):161-177. PubMed ID: 30539678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in Drug Therapy for Metastatic Pancreatic Ductal Adenocarcinoma.
    Gao J; Wang J; Guan C; Shi W; Dong Q; Sheng J; Zou X; Xu Z; Ge Y; Huang Z; Li J; Bao H; Xu Y; Cui Y; Xu X; Zhong X
    J Cancer; 2024; 15(8):2214-2228. PubMed ID: 38495490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of candidate miRNA biomarkers for pancreatic ductal adenocarcinoma by weighted gene co-expression network analysis.
    Giulietti M; Occhipinti G; Principato G; Piva F
    Cell Oncol (Dordr); 2017 Apr; 40(2):181-192. PubMed ID: 28205147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of Blood Plasma MicroRNAs to Enable Identification of Patients with Pancreatic Ductal Adenocarcinoma Who Will Benefit from Surgical Resection.
    Gablo N. A; Procházka V; Hlavsa J; Kiss I; Srovnal J; Kala Z; Slabý O
    Klin Onkol; 2019; 32(Suppl 1):174-176. PubMed ID: 31064193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. microRNA based prognostic biomarkers in pancreatic Cancer.
    Guo S; Fesler A; Wang H; Ju J
    Biomark Res; 2018; 6():18. PubMed ID: 29942514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Challenges and future directions in therapeutics for pancreatic ductal adenocarcinoma.
    Al Haddad AH; Adrian TE
    Expert Opin Investig Drugs; 2014 Nov; 23(11):1499-515. PubMed ID: 25078674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advancement of NF-κB Signaling Pathway: A Novel Target in Pancreatic Cancer.
    Pramanik KC; Makena MR; Bhowmick K; Pandey MK
    Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30563089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pancreatic Cancer Stem Cells and Therapeutic Approaches.
    Ercan G; Karlitepe A; Ozpolat B
    Anticancer Res; 2017 Jun; 37(6):2761-2775. PubMed ID: 28551612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-323-3p inhibits cell invasion and metastasis in pancreatic ductal adenocarcinoma via direct suppression of SMAD2 and SMAD3.
    Wang C; Liu P; Wu H; Cui P; Li Y; Liu Y; Liu Z; Gou S
    Oncotarget; 2016 Mar; 7(12):14912-24. PubMed ID: 26908446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and Validation of Circulating Micrornas as Prognostic Biomarkers in Pancreatic Ductal Adenocarcinoma Patients Undergoing Surgical Resection.
    Gablo N; Trachtova K; Prochazka V; Hlavsa J; Grolich T; Kiss I; Srovnal J; Rehulkova A; Lovecek M; Skalicky P; Berindan-Neagoe I; Kala Z; Slaby O
    J Clin Med; 2020 Jul; 9(8):. PubMed ID: 32751582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of MicroRNAs in Resistance to Current Pancreatic Cancer Treatment: Translational Studies and Basic Protocols for Extraction and PCR Analysis.
    Garajová I; Le Large TY; Giovannetti E; Kazemier G; Biasco G; Peters GJ
    Methods Mol Biol; 2016; 1395():163-87. PubMed ID: 26910074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.